Clinical Trial

An Exploratory Study of Chenghuang Circadian Rhythm Regulator in Subjects With Sleep Disorders

Completed
View on ClinicalTrials.gov →
Summary
This is a single arm, open-label, self-controlled clinical study to evaluate the sleep and immunity improvement of Chenghuang Circadian Rhythm Regulator in adult subjects with sleep disorders.
Trial Details
NCT Number NCT07414381
Lead Sponsor Shanghai Cell Therapy Group Co.,Ltd
Conditions Sleep Disorders
Enrollment 15 participants
Start Date 2025-06-06
Primary Completion 2025-07-18 (estimated)
Study Completion 2025-09-02 (estimated)
Updated on ClinicalTrials.gov 2026-02-17